Hillary Canada writes Alion Science dismissed plans for an initial public offering in favor of the acquisition deal.
Alion Science filed for an IPO in late April, according to the report.
Citing an S&P Capital IQ report, Canada reports UBS AG seeks $340 million in financing package to back the potential purchase.